The highest (3600 IU) reported overdose of insulin glargine ever and management
Sir, Insulin glargine (LANTUS ® SOLOSTAR ® ; Sanofi Aventis, Deutschland) - relatively a new medication in the treatment of diabetes mellitus - is a long-acting insulin for meeting the basal insulin requirement with an ongoing effect up to 24 h. [1],[2] In literature, there are small number of cas...
Gespeichert in:
Veröffentlicht in: | Indian journal of critical care medicine 2015-12, Vol.19 (12), p.750-751 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Sir, Insulin glargine (LANTUS ® SOLOSTAR ® ; Sanofi Aventis, Deutschland) - relatively a new medication in the treatment of diabetes mellitus - is a long-acting insulin for meeting the basal insulin requirement with an ongoing effect up to 24 h. [1],[2] In literature, there are small number of cases regarding with overdose use of insulin glargine. In these cases, intensive care physicians should immediately initiate continuous dextrose infusions, and the patients should be monitored closely with frequent blood glucose samples to prevent the risk of prolonged hypoglycemia episodes. |
---|---|
ISSN: | 0972-5229 1998-359X |
DOI: | 10.4103/0972-5229.171418 |